Qi-Dong-Huo-Xue-Yin balances the immune microenvironment to protect against LPS induced acute lung injury.

COVID-19 induces acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and leads to severe immunological changes that threatens the lives of COVID-19 victims. Studies have shown that both the regulatory T cells and macrophages were deranged in COVID-19-induced ALI. Herbal drugs have long been utilized to adjust the immune microenvironment in ALI. However, the underlying mechanisms of herbal drug mediated ALI protection are largely unknown. This study aims to understand the cellular mechanism of a traditional Chinese medicine, Qi-Dong-Huo-Xue-Yin (QD), in protecting against LPS induced acute lung injury in mouse models. Our data showed that QD intrinsically promotes Foxp3 transcription via promoting acetylation of the Foxp3 promoter in CD4+ T cells and consequently facilitates CD4+CD25+Foxp3+ Tregs development. Extrinsically, QD stabilized ß-catenin in macrophages to expedite CD4+CD25+Foxp3+ Tregs development and modulated peripheral blood cytokines. Taken together, our results illustrate that QD promotes CD4+CD25+Foxp3+ Tregs development via intrinsic and extrinsic pathways and balanced cytokines within the lungs to protect against LPS induced ALI. This study suggests a potential application of QD in ALI related diseases.

An investigation of PM2.5 concentration changes in Mid-Eastern China before and after COVID-19 outbreak.

With the Chinese government revising ambient air quality standards and strengthening the monitoring and management of pollutants such as PM2.5, the concentrations of air pollutants in China have gradually decreased in recent years. Meanwhile, the strong control measures taken by the Chinese government in the face of COVID-19 in 2020 have an extremely profound impact on the reduction of pollutants in China. Therefore, investigations of pollutant concentration changes in China before and after COVID-19 outbreak are very necessary and concerning, but the number of monitoring stations is very limited, making it difficult to conduct a high spatial density investigation. In this study, we construct a modern deep learning model based on multi-source data, which includes remotely sensed AOD data products, other reanalysis element data, and ground monitoring station data. Combining satellite remote sensing techniques, we finally realize a high spital density PM2.5 concentration change investigation method, and analyze the seasonal and annual, the spatial and temporal characteristics of PM2.5 concentrations in Mid-Eastern China from 2016 to 2021 and the impact of epidemic closure and control measures on regional and provincial PM2.5 concentrations. We find that PM2.5 concentrations in Mid-Eastern China during these years is mainly characterized by "north-south superiority and central inferiority", seasonal differences are evident, with the highest in winter, the second highest in autumn and the lowest in summer, and a gradual decrease in overall concentration during the year. According to our experimental results, the annual average PM2.5 concentration decreases by 3.07 % in 2020, and decreases by 24.53 % during the shutdown period, which is probably caused by China's epidemic control measures. At the same time, some provinces with a large share of secondary industry see PM2.5 concentrations drop by more than 30 %. By 2021, PM2.5 concentrations rebound slightly, rising by 10 % in most provinces.

Real-Time Monitoring and Early Warning of a Cytokine Storm In Vivo Using a Wearable Noninvasive Skin Microneedle Patch.

A cytokine storm may be the last attack of various diseases, such as sepsis, cancer, and coronavirus disease 2019, that can be life threatening. Real-time monitoring of cytokines in vivo is helpful for assessing the immune status of patients and providing an early warning of a cytokine storm. In this study, a functional carbon nanotube biointerface-based wearable microneedle patches for real-time monitoring of a cytokine storm in vivo via electrochemical analysis are reported. This wearable system has sensitivity with a detection limit of 0.54 pg mL-1 , high specificity, and 5 days of stability with a coefficient of variation of 4.0%. The system also has a quick response of several hours (1-4 h) to increasing cytokines. This wearable microneedle patch may offer a promising route for real-time biomolecule wearables construction. The patch is also the first reported integrated capture and monitoring system that is capable of real-time measurement of protein markers in interstitial fluid.

Plasmonic Biosensors with Nanostructure for Healthcare Monitoring and Diseases Diagnosis.

Nanophotonics has been widely utilized in enhanced molecularspectroscopy or mediated chemical reaction, which has major applications in the field of enhancing sensing and enables opportunities in developing healthcare monitoring. This review presents an updated overview of the recent exciting advances of plasmonic biosensors in the healthcare area. Manufacturing, enhancements and applications of plasmonic biosensors are discussed, with particular focus on nanolisted main preparation methods of various nanostructures, such as chemical synthesis, lithography, nanosphere lithography, nanoimprint lithography, etc., and describing their respective advances and challenges from practical applications of plasmon biosensors. Based on these sensing structures, different types of plasmonic biosensors are summarized regarding detecting cancer biomarkers, body fluid, temperature, gas and COVID-19. Last, the existing challenges and prospects of plasmonic biosensors combined with machine learning, mega data analysis and prediction are surveyed.

Single-injection COVID-19 subunit vaccine elicits potent immune responses.

Current vaccination schedules, including COVID-19 vaccines, require multiple doses to be administered. Single injection vaccines eliciting equivalent immune response are highly desirable. Unfortunately because unconventional release kinetics are difficult to achieve it still remains a huge challenge. Herein a single-injection COVID-19 vaccine was designed using a highly programmable release system based on dynamic layer-by-layer (LBL) films. The antigen, S1 subunit of SARS-CoV-2 spike protein, was loaded in CaCO₃ microspheres, which were further coated with tannic acid (TA)/polyethylene glycol (PEG) LBL films. The single-injection vaccine was obtained by mixing the microspheres coated with different thickness of TA/PEG films. Because of the unique constant-rate erosion behavior of the TA/PEG coatings, this system allows for distinct multiple pulsatile release of antigen, closely mimicking the release profile of antigen in conventional multiple dose vaccines. Immunization with the single injection vaccine induces potent and persistent S1-specific humoral and cellular immune responses in mice. The sera from the vaccinated animal exhibit robust in vitro viral neutralization ability. More importantly, the immune response and viral inhibition induced by the single injection vaccine are as strong as that induced by the corresponding multiple dose vaccine, because they share the same antigen release profile. STATEMENT OF SIGNIFICANCE: Vaccines are the most powerful and cost-effective weapons against infectious diseases such as COVID-19. However, current vaccination schedules, including the COVID-19 vaccines, require multiple doses to be administered. Herein a single-injection COVID-19 vaccine is designed using a highly programmable release system. This vaccine releases antigens in a pulsatile manner, closely mimicking the release pattern of antigens in conventional multiple dose vaccines. As a result, one single injection of the new vaccine induces an immune response and viral inhibition similar to that induced by the corresponding multiple-dose vaccine approach.

Overview of SARS-CoV-2 distribution in human tissues and prolonged shedding in body fluids

Although the ongoing pandemic coronavirus disease 2019 (COVID-19)caused by SARS-CoV-2 has lasted for over one year, its pathogenesis mechanisms have not been comprehensively elucidated. This review summarized the distribution of viral receptors in human tissues, clinical manifestation of COVID-19 in diverse organs, the broad organotropism of SARS-CoV-2 in multiple organs based on autopsy reports, and evidence concerning virus distribution in human tissues and viral shedding in body fluids. These etiological results will shed new light on the current view of pathogenesis mechanisms of SARS-CoV-2, facilitate in rational choosing of diagnostic specimens and interpretating diagnostic results, promote patient management and treatment, and contribute to combating the pandemic COVID-19 in the near future.

Overview of SARS-CoV-2 viral load and its clinical value

During the unprecedented COVID-19 pandemic, detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral nucleic acids in diverse specimens from patients, people with suspected infection and their close contacts has been widely implemented in infection confirmation, patient management and transmission prevention. Viral nucleic acid detection results not only reflect the infection status in suspected cases, but also are used to quantify positive specimens in most assays. For most viral diseases, viral loads are theoretically associated with potent infectivity and prognostic outcomes in patients. In this review, the principles and characteristics of SARS-CoV-2 viral load detected by real time reverse transcription PCR (RT-PCR) and digital PCR are summarized. The distribution and dynamic changes in viral load in humans are discussed, and the correlations of viral load with disease severity, infectivity and prognostic indicators are analyzed. The comprehensive descriptions of COVID-19 characterization will help guide current practices in infection control, patient treatment and management, and combating the ongoing COVID-19 pandemic.

Corporate Responses to COVID-19: A Nonmarket Strategy Approach

The COVID-19 pandemic has been an unprecedented threat to the survival of U.S. firms. Prior studies show that firms use market strategies such as layoffs and pay cuts to cope with organizational crises. Little is known about how firms engage in corporate social responsibility (CSR) and corporate political activities (CPA) during crises. This study focuses on how America?s largest publicly traded firms use these two nonmarket strategies to cope with the COVID-19 pandemic. Results suggest that public firms actively engaged in both CSR and CPA after the outbreak. The preliminary estimation shows that firms listed in Russell 1000 have donated or pledged over $3.9 billion to corporate philanthropy and invested over 2.1 billion in observed political donations and lobbying in Congress in the early pandemic. The marked variation in corporate nonmarket strategies could be partially attributed to corporate elites? political ideology, political accountability, and perceived COVID-19 risk.

Advance in genomic epidemiology of SARS-CoV-2

To combat the ongoing pandemic COVID-19, considerable resourances have been devoted to genome around the world the causative agent, SARS-CoV-2. As of June 24^th, 2020, more than 55K genome sequences have been aggregated in the EpiCoV database of GISAID web site in less than 6 months, however, genomic epidemiology analysis was challenged by the relatively large genome size and complex coding sequences of SARS-CoV-2. In this review, current progress in genomic epidemiology studies of SARS-CoV-2 was summarized, facilitating professionals to timely understand virus characterization and transmission trends of SARS-CoV-2, make good use of open-source genomic epidemiology platforms to promote the development of vaccines and antiviral drugs, and eventually to suppress spread of this pandemic COVID-19.